OF HIV / AIDS EXPOSURE ACUTE HIV INFECTION (1-2W.) AIDS SEXUAL, BLOOD, VERTICAL Days to weeks(2-4w.) 5-8% *20-25%, 6y. *50%, 10y. *<5%, 2y.
|
|
- Lizbeth Simon
- 5 years ago
- Views:
Transcription
1 Clinical Manifestations & Management of HIV Dr.Shervin Shokouhi Infectious Disease Specialist & Associate Professor of Shaheed Beheshti University of Medical Sciences 1
2 CLINICAL MANIFESTATIONS OF HIV / AIDS SEXUAL, EXPOSURE BLOOD, VERTICAL Days to weeks(2-4w.) ACUTE HIV INFECTION (1-2W.) *<5%, 2y. 5-8% *20-25%, 6y. *50%, 10y. long term nonprogressors NEOPLASM, INFECTIONS AIDS 2
3 Natural history of human immunodeficiency virus (HIV) infection 3
4 4
5 CLINICAL CATEGORIES Category A: Asymptomatic HIV infection -persistent generalised lymphadenopathy )PGL( - Acute (primary) HIV infection Category B : bacillary angiomatosis candidiasis (thrush) in the mouth candidiasis of the vagina and/or vulva cervical abnormalites of moderate or severe extent constitutional symptoms herpes zoster (shingles) involving at least one episodes or more than one dermatone (skin area( idiopathic thrombocytopenia purpura listeriosis oral hairy leukoplakia Category C : AID s Indicator Conditions 5
6 6
7 7
8 Acute Retroviral Syndrome A mononucleosis-like like illness (1/2-2/3) 2/3) Onset 1-6w after exposure, peak at 3w. Fever,sweats,adenopathy,nonexudative adenopathy nonexudative pharyngitis, myalgia or arthralgia, nausea,diarrhea, rash:maculopapular,urticarial,roseaola-like.( like.(2/3) Headache, photophobia, meningismus, encephalitis, peripheral neuropathy, GBS Hepatosplenomegaly, oral aphthous ulceration, oral & esophageal candidiasis 8
9 Lymphadenopathy &Maculopapular lar rash 9
10 Laboratory evaluation ation Reduced total Lymphocyte count: (CD4 & CD8 with normal ratio, within several weeks CD4 & CD8 increase with CD4/CD /CD8 inverted). Elevated ESR Negative heterophile antibody Elevated transaminase & alkaline phosphatase levels HIV Vco core(p24 24) )a antigen tge in serum &CS CSF (75 75%) Plasma HIV RNA test (>10,000) the most sensitive marker Enzyme immunoassay HIV Ab remains negative w
11 Differential Diagnosis Infectious mononucleosis Influenza Viral hepatitis i Measles Rubella Primary herpes simplex infection Secondary syphilis 11
12 Evaluation of patients with Acute Retroviral Rt ls Syndrome Careful history to elicit risks for HIV infection Laboratory tests to rule out Mononucleosis & Syphilis, HIV antibody, Plasma RNA test CBC & diff 12
13 Persistent Generalized Lymphadenopathy Presence of 2 or more extrainguinal sites of lymphadenopathy for min. 3-6 m, which no other explanation % of HIV infected patients Cervical, submandibular, occipital, axillary Symmetric, mobile, rubbery L. N, 0.5-2cm, no pain, no tenderness Pathology: fullicular hyperplasia without specific pathogen 13
14 Differential Diagnosis HIV infection Sarcoidosis Secondary syphilis Hodgkin disease Mycobacterial infection KS Lymphoma Castleman disease 14
15 15
16 Constitutional & Wasting Being easily fatigued, low grade fever, night sweats, intermittent diarrhea Severe wasting Anxiety y, depression 16
17 Wasting Syndrome Definition of wasting syndrome is the presence of unexplained constitutional disease for more than 1 month with a temperature greater than 38.3 C, diarrhea, and loss of more than 10% of baseline body weight. A thorough evaluation to identify specific pathogens that would explain the symptoms and that might be amenable to treatment is essential before wasting syndrome is diagnosed, and usually a specific cause can be implicated. 17
18 Oral Candidiasis Oral Diseases Oral Hairy Leukoplakia Gingivitis i i i & Periodontitis i i Oral ulcers KS NON-Hodgkin lymphoma Oral wart 18
19 Oral Candidiasis Types: Thrush (most common form ) Atrophic form of candidiasis Hypertrophic form Angular chelitis Diagnosis of candidiasis: Physical examination KOH preparation of scraped material from a plaque is diagnostic Cultures from Candida (rarely) Biopsy 19 Therapeutic trial of antifungal agents
20 Oral Candidiasis (thrush) 20
21 Angular cheilitis 21
22 Oral Hairy Leukoplakia Replication of EBV in epithelium of keratinaized cells on the surface of tongue & buccal mucosa. Raised white lesion of oral mucosa, usually on lateral margin of tongue Usually asymptomatic,large lesions impair taste, discomfort Diagnosis by : 1/ visual inspection 2/ failure to scrap off lesion with a tongue blade 3/ failure of lesion to respond to antifungal therapy 4/ biopsy material or scraping (EBV) Therapy: High dose acyclovir or gancyclovir, podophyllin, isotretinoin 22 only temporarily
23 Oral Hairy Leukoplakia 23
24 Human Papiloma Virus 24
25 Oral ulcers HSV 1 & 2 CMV & HPV* Aphthous stomatitis Kaposi Sarcoma* & N. H. Lymphoma* Drugs*(AZT, ddc, Dapson) 25
26 Herpes simplex 26
27 Aphthous ulcer 27
28 Kaposi Sarcoma 28
29 29
30 Herpes zoster in dermatomal distribution tion 30
31 Molluscum Contagiosum 31
32 Kaposi s Sarcoma 32
33 Seborrheic Dermatitis 33
34 Eosinophilic dermatitis 34
35 Cryptococcosis 35
36 Norwegian scabies (in a patient t with wasting syndrome) 36
37 Onychomycosis 37
38 Bacillary Angiomatosis 38
39 Musculoskeletal Complications Polymyositis Pyomyositis ii Other rheumatologic findings in patients with HIV disease are not unusual. Avascular necrosis of bone 39
40 Renal Disease HIV-related nephropathy other causes: IVDU, hepatitis B and C infection, hypertension, fluid and electrolyte disorders, and concomitant opportunistic infections and malignancies are all associated with renal dysfunction. In addition, many drugs used to treat HIV infection and its associated opportunistic infections are nephrotoxic. Pentamidine, foscarnet, and the aminoglycosides id can cause ATN, and indinavir, sulfadiazine, and intravenous acyclovir can cause intratubular obstruction by crystal formation. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome has been reported in HIV-infected persons. Immune complex mediated mediated glomerular diseases, such as those associated with immunoglobulin A nephropathy have also been reported. 40
41 CD4 Cell Count Ranges for Selected HIV-Related and Non-HIV HIV-Related Respiratory Illnesses CD4 cell count <500 cells/fl Bacterial pneumonia (recurrent) Pulmonary mycobacterial pneumonia (Tuberculous) CD4 cell count <200 cells/fl Pneumocystis jirovecii pne. Cryptococcus neoformans pne. Bacterial pneumonia (associated with bacteremia/sepsis) i Disseminated or extrapulmonary tuberculosis CD4 cell count <100 cells/fl Pulmonary Kaposi's Sarcoma Bacterial pneumonia (Gram- negative bacilli and Staphylococcus aureus increased) Toxoplasma pneumonitis CD4 cell count <50 cells/fl Disseminated Histoplasma capsulatum Disseminated Coccidioides immitis Cytomegalovirus pneumonitis Disseminated Mycobacterium avium complex Disseminated mycobacterium (non-tuberculous) Aspergillus pneumonia Candida pneumonia 41
42 42
43 Screenings for specific diseases for patients presenting with HIV infection 43
44 Tests of questionable or no value in initial evaluation of patient presenting with HIV infection. 44
45 ANTIRETROVIRAL AGENTS Nucleoside and Nucleotide Analogue Reverse. Transcriptase Inhibitors. (NRTI / NdRTI) Non-nucleoside nucleoside Reverse Transcriptase Inhibitors. (NNRTI) Protease Inhibitors. (PI) Entry Inhibitors. CCR5 Antagonists Other Drugs 45
46 Approved Nucleoside Reverse Transcriptase Inhibitor (NRTI) 46
47 Approved Non-Nucleoside Nucleoside Reverse Transcriptase Inhibitor (NNRTI) 47
48 Approved Protease Inhibitor 48
49 Approved Entry Inhibitor 49
50 Estimated t Timeline for Availability of New Antiretrovirals MK-0518 Maraviroc GS-9137 Vicriviroc TNX-355 CXCR4 inhibitors Bevirimat Entry inhibitors (anti-gp120, CCR5) Maturation ti inhibitors Integrase inhibitors Etravirine TMC278 Brecanavir Apricitabine PIs NNRTI NRTI 50
51 51
52 Indications to start HAART Therapy Acute HIV-1 Infection Postexposure Prophylaxis Symptomatic Stage Asymptomatic Stage: 1. CD4 Count < CD4 Count > CD4 Count <
53 53
54 54
55 55
56 Recommended ARV Regimen for NRTI + NRTI + PI. Initial lt Treatment t NRTI + NRTI + NNRTI. NRTI + NRTI + NdRTI. Other Regimens. 56
57 57
58 58
59 Assays for Monitoring Infection Baseline HIV-I I RNA levels: Two measurements separated by 1 to 4 week. After therapy is initiated or changed, it is prudent to check HIV-I RNA levels at least monthly until the nadir is reached, and then at least every 3 to 4 months. A consistent increase in viral load of more than 0.5 log suggests a failing antiretroviral regimen. HIV-I RNA levels in 4-8 w & w. Baseline CD4+T-cell counts: Two measurements separated by 1 to 4 week. CD4+T-cell count should be measured periodically, at least every 3 to 4 months, to monitor immunologic i improvement. 59
60 Virologic & Immunologic failure Virologic failure :on treatment can be defined as a confirmed HIV RNA level >400 copies/ml after 24 weeks, >50 copies/ml after 48 weeks, or a repeated HIV RNA level >400 copies/ml after prior suppression of viremia i to <400 copies/ml. Immunologic Failure :can be defined as failure to increase the CD4 cell count by cells/mm3 above the baseline count over the first year of therapy, or a decrease to 60 below the baseline CD4 cell count on therapy
61 Good Luck 61
Clinical Manifestations of HIV
HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from
More informationMeasure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy
Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:
More informationmedical monitoring: clinical monitoring and laboratory tests
medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify
More information0% 0% 0% Parasite. 2. RNA-virus. RNA-virus
HIV/AIDS and Treatment Manado, Indonesia 16 november HIV [e] EDUCATION HIV is a 1. DNA-virus 2. RNA-virus 3. Parasite 0% 0% 0% DNA-virus RNA-virus Parasite HIV HIV is a RNA-virus. HIV is an RNA virus which
More informationhttp://www.savinglivesuk.com/ HIV Awareness Study Morning 24 th November 2017 Agenda HIV Basics & Stages of HIV HIV Testing, Health Advising & Sexual Health Saving Lives Antiretroviral Medication Antenatal/Postnatal
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease
Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006
More informationHIV- INFECTION WHO case definition for HIV infection 2007 Adults and children 18 months or older HIV infection is diagnosed based on:
HIV- INFECTION Human immunodeficiency virus (HIV) is a blood-borne, sexually transmissible virus (see the image below.) The virus is typically transmitted via sexual intercourse, shared intravenous drug
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationHuman Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS
Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s
More informationDidactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012
Didactic Series Primary HIV Infection Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council
More information2. Clinical Manifestations (Pediatric HIV Infection)
Page 1 of 6 HOUSTON ROMANIA SOUTHERN AFRICA MEXICO HOME CONTACT Friday, July 25, 2003 Pediatric HIV Infection by Mark W. Kline, M.D. 1. Introduction 2. Clinical Manifestations 3. Diagnosis 2. Clinical
More informationChapter 8. Otolaryngological Manifestations of AIDS
Chapter 8. Otolaryngological Manifestations of AIDS Acquired immunodeficiency syndrome (AIDS) first came to medical attention in the early 1980s, when an isolated number of deaths from rare lung infections
More informationGOALS AND OBJECTIVES INFECTIOUS DISEASE
GOALS AND OBJECTIVES INFECTIOUS DISEASE Infectious Disease and HIV Overview: The Infectious Diseases Program at the University of Southern California prepares trainees for the management of problems in
More informationWhy is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities
Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Olga P. Frolova Head of the TB/HIV Health Care Centre, Ministry of Health Social Development,
More informationYear 2002 Paper two: Questions supplied by Jo 1
Year 2002 Paper two: Questions supplied by Jo 1 Question 9 A 37 year old man with known human immunodeficiency virus (HIV) infection for 10 years presents with severe renal colic for which he has no prior
More informationBLOCK 12 Viruses of the ENT
BLOCK 12 Viruses of the ENT Acute infections Introduction Pharyngitis, Common cold, Sinusitis, Otitis media Recurrent infections Herpes zoster oticus Chronic infections HIV and ENT manifestations Neoplasms
More informationHIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body
HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University
More informationINTEGRATING HIV INTO PRIMARY CARE
INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.
More informationProkaryotic Biology. VIRAL STDs, HIV-1 AND AIDS
Prokaryotic Biology VIRAL STDs, HIV-1 AND AIDS Prokaryotic Biology FROM THE CDC VIRAL STDs, HIV-1 AND AIDS VIRAL STDs & CONTACT VIRAL DISEASES A. GENITAL HERPES & COLD SORES 1. HERPES SIMPLEX VIRUS-2 (HHV-2)
More informationOral Manifestations of HIV: Case Studies
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Oral Manifestations of HIV: Case Studies David Spach, MD Principal Investigator and Clinical Director, Northwest AETC Professor of Medicine, Division of Infectious
More informationOther Diagnostic Tests
Other Diagnostic Tests APTIMA HIV-1 RNA Qualitative Assay (approved in Oct 2006) Confirmation test (like Western Blot) Detects RNA of the HIV-1 virus (Nucleic Acid Amplification Test/ NAAT) First test
More informationMedical Overview March 7, Nina Lambert, NP Inova Juniper Program
Medical Overview March 7, 2019 Nina Lambert, NP Inova Juniper Program Nina.lambert@inova.org Inova Juniper Program Sites Offering medical care, case management and mental health for youth and adults who
More information20 Years of Tears and Triumphs
20 Years of Tears and Triumphs A Clinical Research Nurse s Perspective on HIV/AIDS Bobi Keenan, RN, ACRN Clinical Research Nurse UC Irvine Dept. of Medicine/Infectious Diseases Objectives 1. Understand
More informationOral Health & HIV. Professor Sudeshni Naidoo Department of Community Dentistry University of the Western Cape
Oral Health & HIV Professor Sudeshni Naidoo Department of Community Dentistry University of the Western Cape Importance & relevance of Oral HIV Lesions >70% of HIV+ve patients present with oral manifestations
More informationINITIATING ART IN CHILDREN: Follow the six steps
INITIATING ART IN CHILDREN: Follow the six steps STEP 1: DECIDE IF THE CHILD HAS CONFIRMED HIV INFECTION Child < 18 months: HIV infection is confirmed if the PCR is positive and the VL is more than 10,000
More informationNewly diagnosed HIV patient. Dr. Heila Redpath 06 FEBRUARY 2014
Newly diagnosed HIV patient Dr. Heila Redpath 06 FEBRUARY 2014 PRIMARY HIV INFECTION: SEROCONVERSION SYMPTOMATIC HIV INFECTION AND AIDS ASYMPTOMATIC LATENT INFECTION CLOSED CIRCLES: CD4 cells OPEN
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationPROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
More informationHIV and AIDS. Shan Nanji
HIV and AIDS Shan Nanji HIV 2 Description: Enveloped Positive Sense HIV 3 Structural Genes: Cleavage of gp160 leads to formation of ENV: Gp120: attachment to host CD4 T Cell Gp41: GAG (p24) Capsid protein
More informationEpidemiology Testing Clinical Features Management
Jason Cronin, MD Epidemiology Testing Clinical Features Management In 1981, 1 the first cases of AIDS were identified among gay men in the US. However, scientists later found evidence that the disease
More information10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission
Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier
More informationHuman Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU
Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU HERPES VIRUS INFECTIONS objectives: ØTo know the clinically important HHVs. ØTo
More informationObjectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.
1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships
More informationSTANDARD OPERATING PROCEDURES
STANDARD OPERATING PROCEDURES ON VIRAL LOAD MONITORING FOR ICAP CLINICAL STAFF AND HEALTH CARE WORKERS Version 1.1 July 2016 A Template Document for Country Adaptation ACKNOWLEDGMENTS This document was
More informationDiagnosing HIV Infection AMNERIS E. LUQUE, M.D. PROFESSOR OF MEDICINE/INFECTIOUS DISEASES MEDICAL DIRECTOR, PARKLAND HIV SERVICES
Diagnosing HIV Infection AMNERIS E. LUQUE, M.D. PROFESSOR OF MEDICINE/INFECTIOUS DISEASES MEDICAL DIRECTOR, PARKLAND HIV SERVICES Disclosures None Objectives 1. Outline the CDC recommendations for HIV
More informationOI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco
OI prophylaxis When to start, when to stop Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco Learning Objectives o Recognize when to start OI prophylaxis
More informationLisa K. Fitzpatrick, MD, MPH Associate Professor of Medicine Howard University School of Medicine
Lisa K. Fitzpatrick, MD, MPH Associate Professor of Medicine Howard University School of Medicine HIV Testing Missed Opportunities Acute Retroviral Syndrome Opportunistic Infections Treatment Reminders
More informationThe Italian AIDS Epidemic Supports The Chemical AIDS Theory. Daniele Mandrioli
The Italian AIDS Epidemic Supports The Chemical AIDS Theory Daniele Mandrioli EPIDEMIOLOGY France Population: 65.073.482 AIDS Incidence: 16/million Germany Population: 82.438.000 AIDS Incidence: 4/million
More informationDiagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know
Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013
More informationInfections in immunocompromised host
Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary
More informationMultiple Choice Questions - Paper 1
Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could
More informationTB Intensive Tyler, Texas December 2-4, Tuberculosis and HIV Co-Infection. Lisa Y. Armitige, MD, PhD. December 4, 2008.
TB Intensive Tyler, Texas December 2-4, 2008 Tuberculosis and HIV Co-Infection Lisa Y. Armitige, MD, Ph.D. December 4, 2008 Tuberculosis and HIV Co Infection Lisa Y. Armitige, MD, PhD Assistant Professor
More information5/15/2017. What Does HIV/AIDS Look Like in DC in Potpourri of Challenges With Opportunistic Infections
Potpourri of Challenges With Opportunistic Infections Henry Masur, MD Clinical Professor of Medicine George Washington University Washington, DC FORMATTED: 4/28/217 Learning Objectives After attending
More informationCh 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems
Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),
More informationTB/HIV Co-Infection. Tuberculosis and HIV
TB Intensive Tyler, Texas June 2-4, 2010 TB/HIV Co-Infection Lisa Y Armitige, MD, PhD June 3, 2010 Tuberculosis and HIV Co-Infection Lisa Y Armitige, MD, PhD Medical Consultant Heartland National TB Center
More informationUpdates in HIV Medicine. Dr. Jacky Chan Associate Consultant Princess Margaret Hospital
Updates in HIV Medicine Dr. Jacky Chan Associate Consultant Princess Margaret Hospital What is HIV? HIV - Human immunodeficiency virus Retrovirus Human Immunodeficiency virus type-1 (HIV-1) Global AIDS
More informationMortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013
John F. White III, MD, MBA, FLMI VP and Medical Director American National Insurance Company 1 Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 2 1 3 My Opinions
More informationThe how and why of Acute HIV Infection 1. How do we best diagnosis patients with acute HIV?
Acute HIV infection Eric Rosenberg, MD Associate Professor of Pathology Director, Clinical Microbiology Laboratory Massachusetts General Hospital Harvard Medical School The how and why of Acute HIV Infection
More informationHIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital
HIV AND LUNG HEALTH Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital Introduction HIV infection exerts multiple effects on pulmonary immune responses: Generalised state of immune
More informationImmunodeficiency. (2 of 2)
Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related
More information2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California SUNDAY, FEBRUARY 8, 2015: 10:00am - 11:00am Primary Care of the HIV Patient Presented by Jim Lee,
More informationHIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018
HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018 Overview Overview recent trends in HIV incidence in the U.S. HIV screening
More informationOUTCOME CODES FOR MACS STATUS FORM
OUTCOME CODES FOR MACS STATUS FORM CODE CDC-DEFINED AIDS DIAGNOSES (Section C) 01 Kaposi's sarcoma 02 Pneumocystis carinii pneumonia 03 Toxoplasmosis (at a site other than or in addition to liver, spleen,
More informationVZV, EBV, and HHV-6-8
VZV, EBV, and HHV-6-8 Anne Gershon Common Features of Herpesviruses Morphology Basic mode of replication Primary infection followed by latency Ubiquitous Ability to cause recurrent infections (reactivation
More informationDoctor, I Have Strep Throat. Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018
Doctor, I Have Strep Throat Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018 Disclosures None The Patient: 41YOF CC: Sore throat x 3 days HPI: Sore throat increasing
More informationWHO/Euro Report of the Technical Consultation on Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance
WHO/EURO REPORT OF THE TECHNICAL CONSULTATION ON CLINICAL STAGING OF HIV/AIDS AND HIV/AIDS CASE DEFINITIONS FOR SURVEILLANCE Copenhagen, Denmark 24 26 May 2005 WHO/Euro Report of the Technical Consultation
More informationMedical monitoring: Clinical monitoring and laboratory tests
medical monitoring: clincial monitoring and laboratory tests: 1 medical monitoring: clinical monitoring and laboratory tests Medical monitoring: Clinical monitoring and laboratory tests Aims This section
More informationOtolaryngologic manifestations of HIV infection
REVIEWS Otolaryngologic manifestations of HIV infection B. Viswanatha, Nisha Krishna Bangalore Medical College & Research Institute, Bangalore, India Correspondence: B.VISHWANATH. Address: ENT Department,
More informationImunodeficiency states
Imunodeficiency states Primary Caused by defined genetic defects Usually rare, but severe (exception: IgA deficiency) Secondary Consequence of some other disease, treatment, environmental factors Usually
More informationHIV IN OKLAHOMA MAKING A DIFFERENCE
HIV IN OKLAHOMA MAKING A DIFFERENCE Madhuri Lad, DO, FACOI, AAHIVS Assistant Program and Medical Director OSU Internal Medicine Specialty Services HIV Program Clinical Assistant Professor Rashes Demographics
More informationHuman Herpesviruses. VZV, EBV, and HHV-6-8. The rash of VZV is vesicular. MID 34
VZV, EBV, and HHV-6-8 Anne Gershon Human Herpesviruses Replication (lytic infection) occurs in a cascade Latency occurs when the cascade is interrupted Transcription of viral genome and protein synthesis
More informationHUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version
1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus
More informationHIV Update: What the Hospital-Based Provider Should Know
HIV Update: What the Hospital-Based Provider Should Know Steven C. Johnson M.D. Division of Infectious Diseases, University of Colorado School of Medicine October 6, 2011 45 year old female Case Study
More informationTreatment of HIV-1 in Adults and Adolescents: Part 2
Treatment of HIV-1 in Adults and Adolescents: Part 2 Heather E. Vezina, Pharm.D. University of Minnesota Laboratory Medicine & Pathology Experimental & Clinical Pharmacology wynnx004@umn.edu Management
More informationUnderstanding Viruses CHAPTER 38. Antiviral Agents. Understanding Viruses (cont'd) Viral Infections (cont'd) Viral Infections.
Understanding Viruses CHAPTER 38 Antiviral Agents Viral replication A virus cannot replicate on its own It must attach to and enter a host cell It then uses the host cell s energy to synthesize protein,
More informationPrinciples of Antiretroviral Therapy
Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationInfectious Mononucleosis The Virus Pathophysiology: Age: History: Fever. Lymphadenopathy
Infectious Mononucleosis The Virus A member of the Herpesvirus family Infects human B lymphocytes Herpes viruses contain double-stranded DNA, and they have an icosahedral capsid and a glycoprotein-containing
More informationHIV/AIDS. Mary White NFSC 471
HIV/AIDS Mary White NFSC 471 Outline HIV history Pathophysiology MNT/Nutritional Implications Case Study ADIME History of HIV/AIDS 1980 s first awareness of AIDS (1) Hypothesis that up to 300,000 infected
More informationPHCP 403 by L. K. Sarki
PHCP 403 by L. K. Sarki objectives To gain insight into the epidemiology of HIV To gain basic understanding of the etiology of HIV disease To know the clinical manifestations of the disease To gain a basic
More informationStudents. Exhibit - Reporting and Exclusion Requirements for Common Communicable Disease. Reporting Mandated to Local Health Authority
August 2003 7:280-E2 Students Exhibit - Reporting and Exclusion Requirements for Common Communicable s Animal Bites (potential for rabies) Bacterial Vaginosis Chancroid As soon as possible, but within
More informationRepetitorium of selected human viruses HIV
Repetitorium of selected human viruses HIV Chair and Department of Medical Microbiology Poznan University of Medical Sciences Chairman: prof. dr hab. Andrzej Szkaradkiewicz Wieniawskiego Street 3, 61-712
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationChapter 22. Autoimmune and Immunodeficiency Diseases
Chapter 22 Autoimmune and Immunodeficiency Diseases Autoimmune Diseases Failures of self-tolerance Immune system fails to distinguish selfantigens from foreign antigens This results in the immune system
More informationThe HIV Program UNIT 2 HIV CURRICULUM PARTICIPANT S MANUAL
T F A R D UNIT 2 The HIV Program UNIT 2 BACKGROUND The HIV Program Poverty and lack of access to basic human rights such as adequate nutrition compound the devastating effects of HIV on communities. Comprehensive
More informationMUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS
MUCOCUTANEOUS MANIFESTATIONS OF HIV/AIDS IN ADOLESCENTS Dr. Y.S.MARFATIA Prof. and Head, Dept. Skin & V.D. Medical college, Vadodara LET US CREATE BRILLIANCE TOGETHER MEDICAL COLLEGE, VADODARA Editor in
More informationHIV-associated. infections? Objectives COMMON HIV- ASSOCIATED INFECTIONS
6 HIV-associated infections Before you begin this unit, please take the corresponding test at the end of the book to assess your knowledge of the subject matter. You should redo the test after you ve worked
More informationNothing to disclose.
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital HIV UPDATE FOR THE PRIMARY CARE PROVIDER Nothing to disclose. 1 Outline Epidemiology Screening / testing for HIV
More informationRECORD or PRINT THE CONFIRMATION ID This unique ID is displayed upon successful submission of your answer form.
2013 course two self-study course The Ohio State University College of Dentistry is a recognized provider for ADA CERP credit. ADA CERP is a service of the American Dental Association to assist dental
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationStructured Treatment Interruption in HIV Positive Patients. Leah Jackson, BScPhm Pharmacy Resident HIV Rotation January 23, 2007
Structured Treatment Interruption in HIV Positive Patients Leah Jackson, BScPhm Pharmacy Resident HIV Rotation January 23, 2007 Objectives To become re-acquainted with the basics of HAART for HIV infection
More informationDR. SATTI A/RAHIM SATTI CONSULTANT PEDIATRICION
A I D S IN CHILDREN BY DR. SATTI A/RAHIM SATTI CONSULTANT PEDIATRICION INTRODUCTION AIDS is the end stage of symptomatic HIV infection. HIV infection progresses more rapidly in children than in adults.
More information43. Guidelines on Needle stick Injury
43. Guidelines on Needle stick Injury The following information is abstracted from the South African Department of Health guidelines entitled: Management of Occupational Exposure to the Human Immunodeficiency
More informationPEDIATRIC HUMAN IMMUNO DEFICIENCY VIRUS. IAP UG Teaching slides
PEDIATRIC HUMAN IMMUNO DEFICIENCY VIRUS 1 DISEASE BURDEN There were 3.2 million children living with HIV around the world with 90% residing in sub Saharan Africa Globally, between 2002 and 2013, there
More informationCHIPS APPENDICES: VERSION 2.4
CHIPS APPENDICES: VERSION 2.4 Page number Appendix 1 CDC classification of stages N, A and B 1 Appendix 2 CDC classification of stage C (AIDS) 2 Appendix 3 Definition of body fat changes 3 Appendix 4 Reason
More informationTitle: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years
06-ID-02 Committee: Infectious Disease Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years Statement of problem: Advances in HIV
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationVirology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.
DEVH Virology Introduction Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment. Definitions Virology: The science which study the
More informationHIV A 2017 Update Bill Rooney MD SCOR Global Life
NHOLUA November 14, 2017 HIV A 2017 Update Bill Rooney MD SCOR Global Life Agenda 1 2 3 4 5 The Immune System HIV the illness Prevalence Diagnosis Natural Course Treatment A look at 100 HIV patients Changing
More informationTreatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)
Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV) Amantadine and Rimantadine Use is limited to Influenza A infection. Very effective in preventing infection if
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationHuman Immunodeficiency Virus (HIV)
HIV INFECTION! Human Immunodeficiency Virus (HIV) Infects human cells and causes gradual loss of immune system function, and these immune alterations predispose to the opportunistic infections, neoplasms,
More informationCancer risk and prevention in persons living with HIV/AIDS (PLWHA) Robert Dubrow, MD, PhD Professor of Epidemiology Yale School of Public Health
Cancer risk and prevention in persons living with HIV/AIDS (PLWHA) Robert Dubrow, MD, PhD Professor of Epidemiology Yale School of Public Health Main collaborators Lesley Park Janet Tate Amy Justice Michael
More informationDidactic Series. Fungal Infections: small bother to big mortality
Didactic Series Fungal Infections: small bother to big mortality Christian B. Ramers, MD, MPH Family Health Centers of San Diego Ciaccio Memorial Clinic 8/8/13 ACCREDITATION STATEMENT: University of California,
More information958 HIV: The Initial Physician-Patient Encounter Mayo Clin Proc, September 2002, Vol 77 Table 1. Indications for HIV Screening* High-risk behaviors Mu
Mayo Clin Proc, September 2002, Vol 77 HIV: The Initial Physician-Patient Encounter 957 Concise Review for Clinicians Human Immunodeficiency Virus: The Initial Physician-Patient Encounter MARY J. KASTEN,
More informationMedical monitoring: tests available at central hospitals
medial monitoring: tests available at central hospitals: 1 medical monitoring: tests available at central hospitals Medical monitoring: tests available at central hospitals medial monitoring: tests available
More informationNatural History of Untreated HIV-1 Infection
Opportunistic infections Dr. Guido van den Berk December 2009 HIV [e] EDUCATION Natural History of Untreated HIV-1 Infection 1000 + CD4 Cells 800 600 400 Constitutional Symptoms Early Opportunistic Infections
More informationIndex. B Bacillary angiomatosis versus Kaposi s sarcoma, 515 with HIV/AIDS, Bacterial folliculitis, versus pruritic papular eruption, 455
Dermatol Clin 24 (2006) 571 578 Index Note: Page numbers of article titles are in boldface type. A Actinic dermatitis, with HIV/AIDS, 446 Acute retroviral syndrome, 431 438 acquisition of, 432 clinical
More informationTanzania Dental Journal Vol. 15 No. 1, May 2008
Diagnosis of Oral Lesions associated with HIV/AIDS Hamza O. Department of Oral Surgery and Oral Pathology, MUHAS Hamza O: Diagnosis of Oral Lesions associated with HIV/AIDS. Tanz Dent J 2008; 15 (1): 22-26
More informationHIV 101: Fundamentals of HIV Infection
HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able
More information